Dilliott, Allison A. http://orcid.org/0000-0003-3863-9304
Abdelhady, Abdalla http://orcid.org/0000-0001-9820-3110
Sunderland, Kelly M. http://orcid.org/0000-0002-5003-1935
Farhan, Sali M. K.
Abrahao, Agessandro
Binns, Malcolm A.
Black, Sandra E.
Borrie, Michael
Casaubon, Leanne K.
Dowlatshahi, Dar
Finger, Elizabeth
Fischer, Corinne E.
Frank, Andrew
Freedman, Morris
Grimes, David
Hassan, Ayman
Jog, Mandar
Kumar, Sanjeev
Kwan, Donna
Lang, Anthony E. http://orcid.org/0000-0003-1229-3667
Mandzia, Jennifer
Masellis, Mario
McIntyre, Adam D.
Pasternak, Stephen H. http://orcid.org/0000-0002-0204-0255
Pollock, Bruce G. http://orcid.org/0000-0003-0802-3998
Rajji, Tarek K.
Rogaeva, Ekaterina
Sahlas, Demetrios J.
Saposnik, Gustavo
Sato, Christine
Seitz, Dallas
Shoesmith, Christen
Steeves, Thomas D. L.
Swartz, Richard H.
Tan, Brian http://orcid.org/0000-0002-6513-307X
Tang-Wai, David F.
Tartaglia, Maria C.
Turnbull, John
Zinman, Lorne
Hegele, Robert A. http://orcid.org/0000-0003-2861-5325
,
Funding for this research was provided by:
Ontario Brain Institute (0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188, 0000045188)
Article History
Received: 27 April 2021
Accepted: 27 August 2021
First Online: 28 September 2021
Competing interests
: The authors declare the following financial interests/personal relationships, none of which are in conflict with the work presented herein: E.F. has received personal compensation for serving on a PSP scientific advisory board for Biogen, for serving as a section editor for NeuroImage Clinical, and for serving as a course director for the AAN annual meeting. M.F. is listed on a patent related to methods and kits for differential diagnosis of Alzheimer disease vs frontotemporal dementia using blood biomarkers. D.G. reports honorariums from Sunovion and Paladin Labs Inc. as well as clinical trials with CIHR, Genzyme Corporation/Sanofi Canada, and Eli Lilly and Company. A.E.L. reports consultancy support from Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions; advisory board support form Jazz Pharma, PhotoPharmics, Sunovion; other honoraria from Sun Pharma, AbbVie, Sunovion, American Academy of Neurology and the International Parkinson and Movement Disorder Society; grants from Brain Canada, Canadian Institutes of Health Research, Corticobasal Degeneration Solutions, Edmond J Safra Philanthropic Foundation, Michael J. Fox Foundation, the Ontario Brain Institute, Parkinson Foundation, Parkinson Canada, and W. Garfield Weston Foundation and royalties from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press. M.M. receives salary support from the Department of Medicine at Sunnybrook Health Sciences Centre, the University of Toronto, and the Sunnybrook Research Institute, as well as advisory board support from Arkuda Therapeutics, Ionis Pharmaceuticals, Alector and Wave Life Sciences; royalties from Henry Stewart Talks Ltd; grants paid to institution from Weston Brain Institute, Ontario Brain Institute, Washington University and Canadian Institutes of Health Research outside the submitted work; and clinical trials support from Roche and Alector. G.S. is the Editor-in-Chief of the World Stroke Academy for the World Stroke Organization and receives CME honorarium from Servier and Roche, as well as grants from Roche. M.C.T. receives consultancy support from Biogen and Hoffman-La Roche and is a board member of Alzheimer’s Society of Toronto. The remaining authors declare no competing interests.